Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
Sutela A, Vanninen R, Sudah M, Berg M, Kiviniemi V, Rummukainen J, Kataja V, Kärjä V
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to compare IHC staining of ER, PR and HER-2 in SCNB and surgical specimens from breast carcinomas. SCNB from the tumor center versus 2 mm away were also compared.
Summary of Findings
Concordance between IHC staining of surgical specimens and SCNB was observed in 83% of cases for ER, and 88% of cases for PR and HER-2, and 93% of cases if HER-2 ISH was also performed. The false negative rate from surgical specimens was 14% for ER, 15% for PR and 7% for HER-2 (when ISH was included). In contrast, false negatives in SCNB did not occur for PR and HER-2 (with ISH) and occurred in only 6% of specimens for ER. The center and margins of the tumor were concordant 100% of the time for ER but only 85% of the time for PR and HER-2. The use of three core specimens for IHC staining allowed for 95% sensitivity for ER, and 92% for PR and HER-2, however, the sensitivity increased to 100% for HER-2 if ISH was also used. The addition of further specimens did not increase ER sensitivity, but did increase sensitivity of PR to 100%. In conclusion, SCNB were more sensitive than surgical specimens for ER, PR, and HER-2 staining, but it was necessary to analyze multiple SCNB.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryDNAIn situ hybridizationMorphologyH-and-E microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of tissue acquisition Core needle biopsySurgical resectionBiospecimen Aliquots and Components Biospecimen heterogeneity Biospecimen coreBiospecimen peripheryIn situ hybridization Specific Targeted nucleic acid Human epidermal growth-factor receptorImmunohistochemistry Specific Targeted peptide/protein Estrogen receptorHuman epidermal growth-factor receptorProgesterone receptor